Top Health Care Stocks <\/p>\n
JNJ -0.12% <\/p>\n
PZE -0.72% <\/p>\n
MRK -0.38% <\/p>\n
ABT -0.07% <\/p>\n
AMGN +0.33% <\/p>\n
Health care stocks were broadly higher today with the NYSE Health Care Sector Index adding about 0.5% and shares of health care companies in the S&P 500 climbing 0.3% as a group. <\/p>\n
In company news, Celldex Therapeutics ( CLDX ) rallied Monday after U.S regulators designated the company's rindopepimut drug candidate as a Breakthrough Therapy for adult patients with a specific type of brain tumor. <\/p>\n
The U.S. Food and Drug Administrations uses breakthrough-therapy designation to expedite the development and review of drugs for serious or life-threatening conditions. Typically, the agency makes its decision based on data from at least clinical trial demonstrating the drug may offer substantial improvement over other currently available therapies. <\/p>\n
The company rindopepimut drug candidate targets EGFRvIII-positive glioblastoma, a particularly aggressive form of brain cancer and whose patients often have a worse prognosis than the general glioblastoma population, including shorter long-term survivals. <\/p>\n
<\/p>\n
More: <\/p>\n
Health Care Sector Update for 02\/23\/2015: CLDX,RIGL,SPPI<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Top Health Care Stocks JNJ -0.12% PZE -0.72% MRK -0.38% ABT -0.07% AMGN +0.33% Health care stocks were broadly higher today with the NYSE Health Care Sector Index adding about 0.5% and shares of health care companies in the S&P 500 climbing 0.3% as a group. In company news, Celldex Therapeutics ( CLDX ) rallied Monday after U.S regulators designated the company's rindopepimut drug candidate as a Breakthrough Therapy for adult patients with a specific type of brain tumor Continue reading